# Reducing Nephrotoxicity of Vancomycin: A Prospective Study of Continuous Versus Intermittent Infusion of Vancomycin

> **NCT01720940** · NA · UNKNOWN · sponsor: **National University Hospital, Singapore** · enrollment: 220 (estimated)

## Conditions studied

- Infections Requiring Prolonged Duration (>10 Days) of Vancomycin

## Interventions

- **DRUG:** continuous vancomycin infusion
- **DRUG:** intermittent vancomycin infusion

## Key facts

- **NCT ID:** NCT01720940
- **Lead sponsor:** National University Hospital, Singapore
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-10
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2012-11-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01720940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01720940, "Reducing Nephrotoxicity of Vancomycin: A Prospective Study of Continuous Versus Intermittent Infusion of Vancomycin". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01720940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*